Community Music Event Benefits Cancer Research
A portion of ticket and auction proceeds from the 2012 Rusty Ball will benefit the GIVEHOPE Pancreatic Cancer Research and Awareness Fund. Together with BSI Engineering, GIVEHOPE provides funding support for an ongoing pancreatic cancer research pilot grant program at the UC Cancer Institute. The group awarded its first pilot grant in 2012 to Vladimir Bogdanov, PhD, a pancreatic cancer researcher affiliated with the UC Cancer Institute and UC College of Medicine.
The fifth annual Rusty Ball, hosted by the Rusty Griswolds, will be held on Nov. 10, 2012. Last year this event helped 119 local charities. GIVEHOPE was a beneficiary in 2011 and has been selected again for 2012.
The nonprofit will receive a portion of ticket proceeds and certain auction items. GIVEHOPE will be auctioning two autographed guitarsone signed by the Doobie Brothers, the other by the band Chicagotwo trips to Chicago and a two-flight glider package from the Caesar Creek Soaring Club. Learn more about the event and purchase tickets at http://tickets.therustyball.com/eventperformances.asp?evt=9. Make sure to designate "GIVEHOPE as your beneficiary.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.